Holocene Advisors, LP Alector, Inc. Transaction History

Holocene Advisors, LP

  • $22.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$10.54 - $24.96 $3.61 Million - $8.54 Million
-342,117 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$21.87 - $33.11 $1.23 Million - $1.86 Million
-56,255 Reduced 14.12%
342,117 $8.36 Million
Q1 2020

May 15, 2020
BUY
$16.25 - $35.28 $6.47 Million - $14.1 Million
398,372 New
398,372 $9.61 Million

Others Institutions Holding ALEC

# of Institutions
167
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $149M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email